Fig. 3From: High inter-laboratory variability in the assessment of HER2-low breast cancer: a national registry study on 50,714 Danish patientsFrequency of HER2-low breast cancer among patients with recordings of both HER2 score and status in the eight pathology departments with more than 3000 breast cancer patientsBack to article page